Peptide Therapeutics Market to Hit USD 64.3 Billion by 2031: Says AMR

Rise in the prevalence of chronic diseases and growing awareness among patients about peptide therapeutic advancements drive the growth of the global peptide therapeutics market. By distribution channel, the hospital pharmacies segment held the major share in 2021. By region, however, the market across Asia-Pacific would cite the fastest CAGR by 2031.

Pune, INDIA


Portland, OR, Nov. 04, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Peptide Therapeutics Market was estimated at $33.3 billion in 2021 and is expected to hit $64.3 billion by 2031, registering a CAGR of 6.8% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Download Free Sample Report (309 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/11591

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Market Size in 2031$64.3 Billion
CAGR6.8%
No. of Pages in Report309
Segments CoveredApplication, Route of Administration, Distribution Channel, and Region.
Drivers Rise in the prevalence of chronic diseases
Growing awareness among patients about peptide therapeutic advancements
OpportunitiesHigh growth potential for the oral peptide therapeutics market
RestraintsLow bioavailability of peptides along with the high cost associated with the drug development


Covid-19 scenario-

  • Strong government support for the use of peptides in the creation of the Covid-19 vaccines create an array of chances for peptide adoption, thus accelerating the expansion of the market for peptide treatments.
  • This drift is expected to persist even if the pandemic is almost over.

The global peptide therapeutics market is analyzed across application, route of administration, distribution channel, and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

By application, the others segment held nearly one-third of the total market revenue in 2021, and is expected to dominate by 2031. The oncology segment, on the other hand, would manifest the fastest CAGR of 7.7% throughout the forecast period.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/11591

By route of administration, the parenteral segment garnered more than three-fourths of the total market revenue in 2021, and is expected to dominate by 2031. The oral segment, on the other hand, would project the fastest CAGR of 7.3% throughout the forecast period.

By distribution channel, the hospital pharmacies segment held more than half of the total market revenue in 2021, and is expected to dominate by 2031. The drug store and retail pharmacies segment, simultaneously, would cite the fastest CAGR of 7.2% throughout the forecast period.

Based on region, the global market across North America generated more than two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would manifest the fastest CAGR of 7.6% during the forecast period. The other provinces analyzed through the report include Europe and LAMEA.

The key market players analyzed in the global peptide therapeutics market report include Amgen Inc., Bausch Health Companies Inc, Eli Lilly and company, AbbVie Inc, Takeda Pharmaceutical Company Limited Ever Neuro Pharma Gmbh, Pfizer Inc, GalaxoSmithKline plc, Novo Nordisk, and Sanofi-GSK. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players. 


Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type (Companion Animal, Livestock Animal, and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021-2030

Healthcare IT Market  by Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services), and End User (Healthcare Providers and Healthcare Payers): Global Opportunity Analysis and Industry Forecast, 2021-2030

Medical Case Management Market  by Service (Web-Based Case Management, Field Case Management, Bilingual Field Case Management, Telephonic Case Management), by Case (Chronic Pain Case Management, Independent Medical Examinations, Catastrophic Case Management, Long Term Disability, Short Term Disability), by End Users (Medical Case Management Providers, Healthcare Insurance Companies, Healthcare It Service Providers, Healthcare BPO & KPO Vendors, Corporate Entities, Healthcare Institutions, Venture Capitalists, Government Bodies, Accountable Care Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2030

AI in Healthcare Market by Offering (Software, Hardware, & Services), Algorithm (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Patients, and Payer): Global Opportunity Analysis and Industry Forecast, 2021--2030

Mental Health Market by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, and Other Disorders), Service (Emergency Mental Health Services, Outpatient Counselling, Home-Based Treatment Services, Inpatient Hospital Treatment Services, and Other Services), and Age Group (Pediatric, Adult, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2030


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Follow Us on Blog: https://www.globalhealthcareindustry.com/

 

Contact Data